Clinimix E 205 mg (Sodium Acetate SOLUTION) 205 MG

Clinimix E 205 mg is an intravenous solution containing sodium acetate, designed for nutritional support. This product is manufactured by Baxter Corporation in Canada and is available in a 1000ml pack size.

Strength

205 MG

Pack Size

1000ML

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Clinimix E 205 mg is primarily used for providing essential nutrients to patients who cannot consume food orally. It is often utilized in clinical settings to support patients requiring intravenous nutrition. This solution helps maintain electrolyte balance and supports overall metabolic function.

Side Effects

When administered intravenously, Clinimix E 205 mg delivers sodium acetate directly into the bloodstream. This can help replenish electrolytes and support metabolic processes. Patients may experience improved nutritional status and better overall health outcomes with regular use.

Precautions & Warnings

Clinimix E 205 mg should be administered under medical supervision to ensure proper dosage and monitoring. It is important to follow all safety guidelines provided by healthcare professionals. Patients with certain medical conditions or allergies should consult their healthcare provider before use.

Avoid Interactions

Clinimix E 205 mg may interact with other medications or supplements. It is important to inform your healthcare provider about all medications you are taking. Additionally, interactions with alcohol or other substances should be discussed with a healthcare professional.

Frequently Asked Questions

Clinimix E 205 mg is used for providing essential nutrients to patients who cannot consume food orally, supporting overall metabolic function.

Clinimix E 205 mg is administered intravenously, directly into the bloodstream.

Common effects include replenishing electrolytes and supporting metabolic processes, leading to improved nutritional status.

Yes, it should be administered under medical supervision and safety guidelines should be followed.

Yes, it may interact with other medications or supplements, so it is important to inform your healthcare provider about all medications you are taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.